It is one of the largest single private funding rounds a biotech company in Europe has ever pulled off. German...
Up To Date
Latest News
Biophytis has priced its IPO on Nasdaq Paris. The company aims to raise up to €10.8m to advance its lead drug...
German biotech group Evotec has once more launched a spin-off: Breakpoint Therapeutics GmbH is focusing on...
A new collaboration aims to the urgent fight against antimicrobial resistant bacteria. Lyon-headquartered...
German researchers have found a way to curb the activity of CAR T cells, even while keeping their...
Oncovita has been granted the exclusive license to an immuno-oncolytic measles virus platform developed by the...